TM Editors' note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.

Company: Henan Lingrui Pharmaceutical Company Limited

Bloomberg ticker: 600285 SH

Market cap: US$1,391m

Background: Henan Lingrui Pharmaceutical Company Limited engages in R&D, production, and distribution of medicines. The product range includes emplastrum, tablets, capsules, ointments, applied in the treatment of diabetes mellitus, osteoarthritis, gastropathy, cardiovascular and cerebrovascular diseases, respiratory disease, gynecopathy and dermatopathy.
 

World Class Benchmarking of Henan Lingrui Pharmaceutical

(Click on image to enlarge)

• Profitable Growth rank of 2 was same compared to the prior period’s 2nd rank
• This is World Class performance compared to 390 medium Health Care companies worldwide
• Profitability rank of 2 was better than its Growth rank of 4
• Profitability rank of 2 was the same compared to the prior period’s 2nd rank
• This is World Class performance compared to peers
• Growth rank of 4 was down compared to the prior period’s 3rd rank
• This is above average performance compared to peers

More By This Author:

Asian Stock: Tripod Technology Corp., Taiwan
Asian Stock: Beijing Tongrentang
Asian Stock: Mega Lifesciences